SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001609351-19-000070
Filing Date
2019-08-08
Accepted
2019-08-08 17:14:27
Documents
69
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q spark-201963010xq.htm   iXBRL 10-Q 1889477
2 EXHIBIT 31.1 spark-2019630exx311.htm EX-31.1 21898
3 EXHIBIT 31.2 spark-2019630exx312.htm EX-31.2 21897
4 EXHIBIT 32.1 spark-2019630exx321.htm EX-32.1 6983
5 EXHIBIT 32.2 spark2019630ex-322.htm EX-32.2 6867
  Complete submission text file 0001609351-19-000070.txt   6775764

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT once-20190630.xsd EX-101.SCH 40679
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT once-20190630_cal.xml EX-101.CAL 79794
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT once-20190630_def.xml EX-101.DEF 215314
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT once-20190630_lab.xml EX-101.LAB 642218
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT once-20190630_pre.xml EX-101.PRE 369306
11 EXTRACTED XBRL INSTANCE DOCUMENT spark-201963010xq_htm.xml XML 889667
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36819 | Film No.: 191010569
SIC: 2836 Biological Products, (No Diagnostic Substances)